Evidence Hub

Type 1 Diabetes Mellitus in a Child With Genetically Confirmed Alström Syndrome: An Unusual Autoimmune Phenotype

Alquraishi AS, Al Alammar N, Saad MM, Alqahtani RA

Cureus, 2026

Abstract

Alström syndrome (AS) is a rare autosomal recessive multisystem disorder caused by pathogenic variants in the ALMS1 gene and is classically associated with obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). We report a 9-year-and-10-month-old girl with genetically confirmed Alström syndrome who developed diabetes mellitus at 5 years of age. Unlike the typical metabolic phenotype reported in Alström syndrome, the patient demonstrated positive anti-glutamic acid decarboxylase (GAD) and insulinoma-associated antigen-2 (IA-2) antibodies, progressive decline in endogenous insulin secretion, and persistent insulin dependence, consistent with autoimmune type 1 diabetes mellitus (T1DM). Despite obesity, there were no significant clinical features of severe insulin resistance. Glycemic control progressively deteriorated over follow-up despite intensive insulin therapy. This case highlights the phenotypic variability of diabetes in Alström syndrome and emphasizes the importance of comprehensive endocrine evaluation to ensure accurate diabetes classification and appropriate management.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free